Showing results (581-590 of 601) with videos related to

Sort By:
Pageof 61
Brain : a Journal of Neurology|April 16, 2020
Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosisMichael Dietrich, Valeria Koska, Christina Hecker, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Therapeutic Advances in Neurological Disorders|August 23, 2021
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)Heinz Wiendl, Ralf Gold, Thomas Berger, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Markus Reindl, Albert Saiz, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2021
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum DisordersMarius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2020
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severityPatrick Ostkamp, Anke Salmen, Béatrice Pignolet, et al.
Journal of Medical Genetics|September 14, 2012
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjectsChristina M Lill, Tian Liu, Brit-Maren M Schjeide, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 26, 2022
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference valuesSamuel Arends, Judith Drenthen, Peter van den Bergh, et al.
Pageof 61